{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"67b7b15d6cb133090e3b5201070e6bd523dfc0a3d21d1831cc0d3a24e05da45b","attributes":{"feedName":"medwatch","feedSource":"medwatch","title":"Valsartan-Containing Products: Update Health Professional and Consumer on Recent Recalled Products","description":"The investigation into valsartan-containing products is ongoing and there are currently three voluntary recalls related to the NDMA impurity detected in the valsartan","link":"https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm614030.htm","publicationDate":"2018-07-19T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["drugs"],"contaminants":[],"distribution":["AL","AK","AZ","AR","CA","CO","CT","DE","DC","FL","GA","HI","ID","IL","IN","IA","KS","KY","LA","ME","MD","MA","MI","MN","MS","MO","MT","NE","NV","NH","NJ","NM","NY","NC","ND","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VT","VA","WA","WV","WI","WY"],"risk":"possible","token":"5d9e68828b079e002a25099e"}}}